Together, these results show that the 6 Gy + INDO combination treatment restored tumor immune surveillance against aggressive 4T1 tumors, which involved at least in part enhanced antitumor innate and adaptive immune responses through cGAS/STING/type I IFN signaling. The gene discussed is CGAS; the disease is neoplasm.